Wells Fargo announced that its board plans to appoint CEO Charlie Scharf as chairman and grant him a one-time special equity award worth $30 million in restricted share rights and stock options. The move highlights the board’s intention to retain Scharf and recognize his role in transforming the bank following years of regulatory challenges.
The board stated that a lead independent director will be appointed to maintain oversight once Scharf assumes the chairman role. The bank did not specify the timeline for the transition. According to current chairman Steven Black, the award reflects Scharf’s leadership in driving Wells Fargo’s turnaround, creating shareholder value, and positioning the institution for future growth.
The equity grant also aligns Scharf’s compensation with peers at top U.S. financial institutions, including JPMorgan Chase, Goldman Sachs, and Bank of America, where CEOs also hold chairman roles.
Scharf, 60, took over Wells Fargo in 2019 amid the fallout from the 2016 fake-accounts scandal, which triggered billions in fines and led to a split between the chairman and CEO roles. The bank recently emerged from a seven-year, $1.95 trillion asset cap imposed by regulators, marking a key milestone in its recovery efforts.
The decision comes despite calls from influential proxy advisers to keep the chairman and CEO positions separate to strengthen corporate governance. Similar proposals were rejected by shareholders at Goldman Sachs and Bank of America in 2024.
Wells Fargo’s move underscores renewed confidence in Scharf’s leadership as the bank navigates a post-scandal era and seeks to compete more aggressively with major Wall Street rivals.


Honda Shares Jump as Automaker Forecasts Profit Recovery Despite Historic Loss
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
Standard Chartered Targets Higher Profitability With Major Workforce Cuts
Tencent Shares Jump 4% as AI Models Move Toward Paid Commercial Services
Samsung, Union Edge Closer to Deal as Strike Threat Looms
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor
Elliott Targets Bio-Rad as Shares Continue to Struggle
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes
Stellantis CEO Antonio Filosa to Reveal Turnaround Strategy Focused on U.S. Sales and China Partnerships
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 



